Therapeutic Opportunity Identified in Relapsed Leukemia

Today’s example of metabolomics unlocking biological insights, the fifth in our series, describes how one of Metabolon’s clients made promising progress in overcoming treatment resistance and improving survival in patients with hard-to-treat acute lymphoblastic leukemia (ALL).